We are live on ! Find out more
PRPH

ProPhase Labs
PRPH

Delisted

PRPH was delisted on the 2nd of January, 2026.

Back to rankings

18 hedge funds and large institutions have $1.73M invested in ProPhase Labs in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

29% more funds holding

Funds holding: 14 → 18 (+4)

12% less capital invested

Capital invested by funds: $1.98M → $1.73M (-$241K)

Holders
18
Holders Change
+4
Holders Change %
+28.57%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
U
UBS
Switzerland
+$40.7K
2
Goldman Sachs
Goldman Sachs
New York
+$25.7K
3
VKH
Virtu KCG Holdings
New York
+$24.6K
4
Citadel Advisors
Citadel Advisors
Florida
+$22.2K
5
Renaissance Technologies
Renaissance Technologies
New York
+$12.6K

Top Sellers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$14.9K
2
Federated Hermes
Federated Hermes
Pennsylvania
-$4K

PRPH Hedge Fund Activity: Q3 2014 in Review

18 of the 3,454 institutional investors tracked by Wall St. Rank reported a position in ProPhase Labs (PRPH) for Q3 2014, worth a combined $1.73M — down 12% from $1.98M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new PRPH positions and 1 closed out — a net gain of 4 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was UBS, adding an estimated $40.7K. The largest seller was Dimensional Fund Advisors, cutting an estimated $14.9K.

  • 18 institutional investors held ProPhase Labs (PRPH) as of Q3 2014, up from 14 in Q2 2014.
  • Funds reported $1.73M of ProPhase Labs stock for Q3 2014, down 12% quarter-over-quarter.
  • 5 funds opened new ProPhase Labs positions in Q3 2014 and 1 closed out, a net change of +4 holders.
  • The largest ProPhase Labs buyer in Q3 2014 was UBS, an estimated $40.7K added.
  • The largest ProPhase Labs seller in Q3 2014 was Dimensional Fund Advisors, an estimated $14.9K sold.

Based on aggregated 13F filings for Q3 2014.